Themes for the 2nd Annual Australian Paediatric Immunotherapy Conference 2024 (APIC2024) include:
Tumour microenvironment and immunogenic therapies
Cell based immunotherapy
Tumour antigens and vaccines
PROGRAM
PROGRAM COMMENCEMENT@ The Larwill Studio, Melbourne
Opening Sessions: 8.45am - 10.30am
Welcome & Introduction
Keynote Lecture: Prof Crystal Mackall, Professor, Stanford University
Developing CAR T Cells for Pediatric Solid Cancers
Lecture: Dr Seong Lin Khaw
CD19 CAR T cell therapy for ALL- Lessons and Challenges in 2024
MORNING TEA @ The Larwill Studio 10.30am - 11am
Sessions: 11.00am - 12.20pm : TUMOUR MICROENVIRONMENT AND IMMUNOGENIC THERAPIES
Prof Di Yu, Ian Frazer Centre for Children's Immunotherapy Research, University of Queensland
Regulation of T cell homeostasis and function by ferroptosis
Chelsea Mayoh, CCIA, UNSW
Exploring the tumour immune microenvironment in paediatric cancer
Dr Charlotte S. Chen, Peter MacCallum Cancer Centre
In depth characterisation of the tumour immune microenvironment in paediatric solid tumours
Dr Klaartje Somers, CCIA, UNSW
Reprogramming the tumour microenvironment in solid paediatric cancers to enhance immunotherapy efficacy
Erin Coll, CCIA, UNSW
The chemotactic landscape of paediatric solid tumours
Associate Professor Raelene Endersby, Telethon Kids Institute, Perth
Investigating age-specific changes in the brain cancer immune microenvironment and how this modulates response to therapy
Rob Salomon, CCIA, UNSW
ASpIRe: a national resource for advancing paediatric immune-oncology research
LUNCH @ The Larwill Studio 12.20pm - 1.20pm
Sessions: 1.20pm - 3.30pm: CELL BASED IMMUNOTHERAPY
Dr Allie Lam, UQ Frazer Institute
Empowering Immunotherapy: Harnessing Adoptive NK Cells in the Fight Against Sarcoma
Prof Phil Darcy
Overexpression of FOXO1 in CAR T cells enhances stemness, metabolic fitness and anti-tumour efficacy
Assoc Prof Paul Beavis, Peter MacCallum Cancer Centre
Next generation CRISPR/HDR armoured CAR T cells
Prof Misty Jenkins, WEHI
Developing novel immunotherapies for brain cancer
Vicky Qin, Peter MacCallum Cancer Centre
Engineering a TGF-β switch receptor enhances CAR-T cell fitness and anti-tumor efficacy in immunosuppressive models
Dr Jessica Li, Peter MacCallum Cancer Centre
The Centre of Excellence in Cellular Immunotherapy at Peter Mac
Prof David Zeigler, Sydney Children’s Hospital
Australia’s first Paediatric Brain Cancer CAR T cell trial
AFTERNOON TEA @ The Larwill Studio 3.30pm - 4.00pm
Sessions: 3.00pm - 4.30pm: TUMOUR ANTIGENS AND VACCINES
Dr Pouya Faridi, Hudson Institute of Medical Research / Monash University
Inflammatory Microenvironment and Pediatric Solid Tumors: Implications for Antigenic Landscape and Immunotherapy Strategies
Dr Mohamed Fareh, Peter MacCallum Cancer Centre
RNA targeting with CRISPR-Cas13: From fundamental principles to therapeutic applications
OPEN DISCUSSION 4.30pm - 5.30pm
NETWORKING RECEPTION @ The Farmacy next to the Larwill Studio 5.30pm - 6.30pm
Monday 13 May 2024
* Please note this program is subject to change